Voice Actress Sora Amamiya Diagnosed with Chorditis Vocalis

Her solo tour in this summer is currently set to be held as planned

0
115

The official website for three-member voice actress unit TrySail announced on Saturday that its 24-year-old member Sora Amamiya was diagnosed with chorditis vocalis (inflamed vocal chords) by a doctor. Her throat issues have been reported by the fans recently. She cancelled her appearance in the “SECONDSHOT FES GirlsMembers 2018” event on Saturday, the event’s official website explained the reason was her health issue.

In spite of her problem, Amamiya appeared in the unit’s concert “LAWSON presents TrySail Second Live Tour ‘The Travels of TrySail’ calling at Niigata” on Sunday, along with the other tow members, Momo Asakura and Shiina Natsukawa. The site said her physical condition was fine, except her throat. According to the fans’ reports on the net, she didn’t sing songs at all and only performed without voices, including dancing on the stage.

TrySail

Voice Actress Sora Amamiya Diagnosed with Chorditis Vocalis
Voice Actress Sora Amamiya Diagnosed with Chorditis Vocalis

Her next solo tour is scheduled in this summer as listed below. Current they are set to be held as planned.

  • July 15: Pacifico Yokohama National Convention Hall (Kanagawa)
  • July 29: Orix Theater (Osaka)
  • August 5: Hiigata Terrsa (Niigata)
  • August 11: Fukuoka International Convention Center Main Hall (Fukuoka)
  • August 19: Kobe International House Kokusai Hall
  • September 2: Sendai PIT (Miyagi)

Sora Amamiya’s 6th solo single “Chikai” (The Seven Deadly Sins: Revival of The Commandments 2nd cour ED) was released in Japan on May 9 and ranked 9th in the Oricon daily cahrt on its first day.

“Chikai” Regular edition CD jacket

Voice Actress Sora Amamiya Diagnosed with Chorditis Vocalis
Voice Actress Sora Amamiya Diagnosed with Chorditis Vocalis

First press limited edition

Voice Actress Sora Amamiya Diagnosed with Chorditis Vocalis
Voice Actress Sora Amamiya Diagnosed with Chorditis Vocalis

LEAVE A REPLY

Please enter your comment!
Please enter your name here